XENETIC BIOSCIENCES, INC. Increase (Decrease) in Other Noncurrent Assets
XENETIC BIOSCIENCES, INC. (XBIO) reported Increase (Decrease) in Other Noncurrent Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-06
- XENETIC BIOSCIENCES, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $313.92K.
- XENETIC BIOSCIENCES, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $0.00.
- XENETIC BIOSCIENCES, INC. increase (decrease) in other noncurrent assets for the quarter ending 2024-12-31 was -$704.43K, a 324.40% decline year-over-year.
- XENETIC BIOSCIENCES, INC. increase (decrease) in other noncurrent assets for the quarter ending 2024-09-30 was $0.00.
- XENETIC BIOSCIENCES, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was $0.00.
- XENETIC BIOSCIENCES, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was -$704.43K.
- XENETIC BIOSCIENCES, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was -$48.58K.
- XENETIC BIOSCIENCES, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was -$25.00K, a 108.87% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $313.92K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $313.92K derived: sum of 2 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$313.92K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | -$313.92K 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | -$704.43K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$704.43K derived: sum of 2 quarters · filed 2026-03-12 | -$704.43K derived: sum of 3 quarters · filed 2026-03-12 | -$704.43K 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | $313.92K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | $313.92K derived: sum of 3 quarters · filed 2025-08-12 | $313.92K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $313.92K derived: sum of 2 quarters · filed 2025-03-18 | $313.92K derived: sum of 3 quarters · filed 2025-03-18 | $173.92K derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-12-31 | $313.92K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $313.92K derived: sum of 2 quarters · filed 2025-03-18 | $173.92K derived: sum of 3 quarters · filed 2025-03-18 | -$48.58K 10-K · filed 2025-03-18 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$140.00K derived: sum of 2 quarters · filed 2024-11-12 | -$362.50K 10-Q · filed 2024-11-12 | -$701.42K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$362.50K 10-Q · filed 2024-08-13 | -$701.42K derived: sum of 3 quarters · filed 2024-08-13 | -$387.50K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$222.50K 10-Q · filed 2024-05-09 | -$561.42K derived: sum of 2 quarters · filed 2024-05-09 | -$247.50K derived: sum of 3 quarters · filed 2024-05-09 | -$250.37K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$338.92K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$25.00K derived: sum of 2 quarters · filed 2024-03-21 | -$27.87K derived: sum of 3 quarters · filed 2024-03-21 | -$25.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | $313.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $311.05K derived: sum of 2 quarters · filed 2023-11-09 | $313.92K 10-Q · filed 2023-11-09 | $701.42K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$2.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | $387.50K derived: sum of 3 quarters · filed 2023-08-10 | |
| 2022-03-31 | $2.87K 10-Q · filed 2023-05-11 | $390.37K derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $387.50K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $281.95K 10-K · filed 2023-03-22 | ||
| 2021-09-30 | -$105.56K 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |